The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXC.L Regulatory News (MXC)

  • There is currently no data for MXC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MGC Pharmaceuticals delivers its largest-ever order

8 Dec 2022 13:47

MGC Pharmaceuticals Ltd MGC Pharmaceuticals delivers its largest-ever order 08.12.2022 / 14:46 CET/CEST The issuer is solely responsible for the content of this announcement.


Contact Details

Proactive

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

News Source: News Direct

08.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com


Language:English
Company:MGC Pharmaceuticals Ltd
United States
ISIN:AU000000MXC6
EQS News ID:1508695
 
End of NewsEQS News Service

1508695 08.12.2022 CET/CEST

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
30th Jun 20239:30 amRNSCompany Update
29th Jun 202310:22 amRNSResults of Shareholder’s General Meeting
1st Jun 20237:30 amRNSAppointment of Non-Executive Director
31st May 20237:00 amRNSFirst CannEpil® delivered to UK patients
30th May 20237:01 amRNSCorporate Update - Board and UK Adviser Changes
30th May 20237:00 amRNSDispatch of General Meeting Documents
18th May 202312:00 pmRNSDirector/PDMR Shareholding
10th May 20235:05 pmRNSDirector/PDMR Shareholding
2nd May 20237:00 amRNSMalta Production Facility Receives EU-GMP Approval
28th Apr 20237:13 amRNSMarch 2023 Quarterly Activities and Cash Flow
13th Apr 20237:00 amRNSFundraise closed raising a total of £2,090,890
11th Apr 20237:01 amRNS£1.2 million raised in a conditional Placing
11th Apr 20237:00 amRNSCannEpil® available by Named Patient Request in UK
3rd Apr 20237:00 amRNSApproval to Develop and Research with Psilocybin
21st Mar 20239:05 amRNSSecond Price Monitoring Extn
21st Mar 20239:00 amRNSPrice Monitoring Extension
21st Mar 20237:00 amRNSArtemiC Listed as OTC Drug; AMC Places US$2m order
15th Mar 20234:35 pmRNSPrice Monitoring Extension
15th Mar 20237:00 amRNSFirst patient enrolled in MGC ZAM App
8th Mar 20239:00 amRNSUS$500,000 funding received under Mercer Facility
7th Mar 20237:00 amRNSCompletion of CimetrA™ Mechanism of Action study
1st Mar 20237:02 amRNSAppointment of UK Lead Broker and Change of Co Sec
28th Feb 20239:08 amRNSHalf-year Report
10th Feb 20238:45 amRNSUpdated Investor Presentation
3rd Feb 20237:00 amRNSProvision of US$600,000 funding and change of CFO
2nd Feb 20237:00 amRNSExtension of Convertible Securities Agreements
30th Jan 20237:00 amRNSDecember 2022 Quarterly Activities and Cash Flow
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
16th Jan 20237:00 amRNSChange of Adviser – SW4 Partners
11th Jan 20239:01 amRNSChange in External Financial Auditor
10th Jan 20237:00 amRNSCompletion of CimetrA™ Pre-clinical Trial
3rd Jan 20237:00 amRNSInternal Costs Review Completed and Board Change
28th Dec 20229:10 amRNSA$800,000 funding received under Mercer Facility
8th Dec 20221:47 pmEQSMGC Pharmaceuticals delivers its largest-ever order
7th Dec 20227:00 amRNSCompletion of CimetrA Efficacy Pre-clinical Trial
5th Dec 20227:00 amRNSDelivery of US$1m order of ArtemiC to AMC Holdings
2nd Dec 20227:00 amRNSPublication of MGC Pharma Glioblastoma research
28th Nov 20227:00 amRNSResult of AGM and Investor Presentation
22nd Nov 20227:00 amRNSWebsite Update
16th Nov 20229:00 amRNSNotice of AGM
9th Nov 202210:20 amRNSApplication for Admission to Trading
31st Oct 20227:00 amRNSSeptember Quarterly Activities and Cash Flow
25th Oct 20227:00 amRNSArtemiC Support - Long COVID Clinical Study Resuls
20th Oct 20227:00 amRNSOperations Update – Major Milestones Achieved
18th Oct 20229:00 amRNS2022 AGM Notice of Meeting and Annual Report
5th Oct 20221:03 pmRNSResults of Shareholder’s General Meeting
4th Oct 20227:00 amRNSAppointment of UK Advisor and Company Update
3rd Oct 20227:00 amRNSAnnual Financial Report
28th Sep 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.